正道集團(01188.HK):向法院確認由附屬公司其中一名董事就清盤呈請提出抗辯
格隆匯10月14日丨正道集團(01188.HK)公佈,於2019年9月24日,該附屬公司收到由呈請人提出的清盤呈請。清盤呈請乃根據日期為2019年5月23日的法定要求償債書提出。
公司及該附屬公司已諮詢彼等的法律顧問,基於彼等目前對有關事實之理解,相信該附屬公司有理據就清盤呈請提出辯解。該附屬公司已指示其法律顧問向法院提交一切所需文件,就清盤呈請提出抗辯。於2019年10月8日,該附屬公司透過其法律顧問向法院確認由該附屬公司其中一名董事就清盤呈請提出抗辯。
董事會認為,清盤呈請不會對公司營運及財務狀況造成任何重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.